The results of the investigation are inconclusive at this time, and the reported device was not returned for analysis.Based on the information received, the cause of the reported event could not be conclusively determined.The device history and sterilization record for this device serial number has been reviewed.No issues or discrepancies were noted during this review that would have contributed to the reported event.The device met material, assembly, and quality control requirements.Cvrx id# (b)(4).
|
A barostim system was implanted on (b)(6) 2023.On (b)(6) 2023, the patient reported experiencing worsening hf symptoms, low blood pressure, and dizziness since their last titration on (b)(6) 2023.The patient's blood pressure on (b)(6) 2023 was 95/59.During device programming, the patient became dizzy and experienced low blood pressure of approximately 80/40 to 75/40.It was noted the patient's heartbeat may have been irregular, and the barostim device was turned off for an ekg.The ekg showed frequent premature ventricular contractions.While awaiting transport to the emergency department, the patient's blood pressure improved to 100+/70+, and the premature ventricular contractions were no longer occurring.The patient was admitted to the hospital from (b)(6) to (b)(6).During hospitalization, it was found that there was a 60-70% blockage in a previously stented heart vessel, and the patient had low potassium.Medications were adjusted and a later heart intervention was planned but not scheduled.It was noted the patient's icd was not checked during the hospitalization.The patient noted feeling improved when potassium was administered in the hospital.Barostim therapy was restarted on (b)(6) 2023.The physician was unable to determine if barostim therapy contributed to the event.A follow-up appointment was scheduled for (b)(6) 2023.
|